Brief: Aceso Life Science Says HY Loss Attributable HK$51 Mln
29/11/2022 13:10
Nov 29 (Reuters) - Aceso Life Science Group Ltd
0474.HK :
* HY LOSS ATTRIBUTABLE HK$51 MILLION VERSUS LOSS HK$83
MILLION
* HY REVENUE HK$161 MILLION VERSUS HK$166 MILLION
Source text for Eikon: ID:nHKS6D7qxk
Further company coverage: 0474.HK
Recent news on Aceso Life Science
See all newsBrief: Aceso Life Science Disposes 18.3 Million Future Data Shares From 4 To 8 June
Brief: Aceso Life Science To Subscribe For Imagi Fin Group Shares For HK$167.32 Million
Brief: Aceso Life Science Expected To Record Profit For HY
Brief: Aceso Life Science Says Repaid All Outstanding Indebtedness In Full
Brief: Aceso Life Science Says New Facility Loan Of GBP87.3 Million For 3 Years